The U.S. Food and Drug Administration (FDA) has announced a groundbreaking initiative aimed at improving access…
Blog
FDA Introduces TEMPO Digital Health Pilot to Improve Chronic Disease Care Access
The U.S. Food and Drug Administration (FDA) unveiled the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital…
Triana Secures $120M Series B as Protego Adds $130M, Marking Major December Biotech Fundraises
Meta description: Triana Biomedicines raises $120 million in a Series B while Protego Biopharma secures $130…
Swissmedic Launches 2025 Oversight Fee Self-Declaration: Key Details for Medical Device Professionals
Swissmedic, Switzerland’s authority for therapeutic products, has announced the self-declaration deadline for the 2025 oversight fee.…
Swissmedic Expands Therapeutic Indication for Jemperli®
On December 5, 2025, Swissmedic announced an extension to the therapeutic indication for Jemperli®, emphasizing its…
Swissmedic Announces New Extension of Indication for Tevimbra®
On December 5, 2025, Swissmedic published an update regarding the therapeutic indication of Tevimbra®. This regulatory…
Swissmedic Expands Tevimbra® Indication: Key Regulatory Update
Swissmedic, the Swiss Agency for Therapeutic Products, has officially announced the approval of an extended therapeutic…
FDA Grants Conditional Approval for Cattle Treatment Addressing New World Screwworm and Fever Ticks
The U.S. Food and Drug Administration (FDA) has granted conditional approval for Exzolt Cattle-CA1 (fluralaner), a…
FDA Grants Approval to First CAR T-Cell Therapy for Marginal Zone Lymphoma in the U.S.
The U.S. Food and Drug Administration (FDA) has issued its approval for Breyanzi (lisocabtagene maraleucel) as…
Offre d’emploi : Manipulateur en électroradiologie médicale à Romainville (CDI)
Offre publiée le : 29 novembre 2025 Une clinique située aux portes de Paris, à proximité…